Literature DB >> 16771758

Effects of mydriatics on intraocular pressure and pupil size in the normal feline eye.

Katrin Stadtbäumer1, Florian Frommlet, Barbara Nell.   

Abstract

OBJECTIVE: To determine the effect of various mydriatics (1% atropine, 1% cyclopentolate, 0.5% tropicamide, 10% phenylephrine) on intraocular pressure (IOP) and pupil size (PS) in normal cats. ANIMALS STUDIED: The mydriatics were tested in 10 adult ophthalmoscopically normal European Domestic Short-haired cats. Procedure Single-dose drug studies were divided into placebo (vehicle of phenylephrine), 10% phenylephrine, 0.5% tropicamide, 1% cyclopentolate and 1% atropine. After measurement of IOP and pupil size (PS) at 8 a.m. on the first day, one drop of the tested drug was applied to one randomly selected eye. The IOP and PS were measured for a minimum of 36 h until the pupil returned to pretest size.
RESULTS: Ten per cent phenylephrine had no significant effect on IOP, and the effect on the pupil size was minimal (<or= 1 mm difference). One per cent atropine showed a maximal mean difference of 4.3 mmHg +/- 4.1 mmHg in IOP compared to the untreated eye. These differences were statistically significant at 1, 3, 6, 12 and 16 h post-treatment. At 1, 1.5 and 2 h after unilateral application of 1% cyclopentolate, the IOP in the treated eye was significantly higher than the IOP in the untreated eye with a maximal mean difference of 4.1 mmHg +/- 4.5 mmHg. With 0.5% tropicamide, IOP of the treated eye was significantly higher than IOP of the untreated eye at 1 and 1.5 h after treatment with a maximal mean difference of 3.5 mmHg +/- 3.3 mmHg. One per cent atropine caused the greatest increase in IOP, followed by 1% cyclopentolate and 0.5% tropicamide. The dilating effect of atropine, cyclopentolate and tropicamide lasted longer than the effect on intraocular pressure.
CONCLUSIONS: The parasympatholytics 1% atropine, 1% cyclopentolate and 0.5% tropicamide caused a statistically significant elevation of IOP and produced mydriasis in the treated eye in normal cats, while the sympathomimetic 10% phenylephrine had no significant effect on IOP or pupil size.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16771758     DOI: 10.1111/j.1463-5224.2006.00474.x

Source DB:  PubMed          Journal:  Vet Ophthalmol        ISSN: 1463-5216            Impact factor:   1.644


  7 in total

Review 1.  Feline glaucoma--a comprehensive review.

Authors:  Gillian J McLellan; Paul E Miller
Journal:  Vet Ophthalmol       Date:  2011-09       Impact factor: 1.644

2.  Effects of unilateral topical administration of 0.5% tropicamide on anterior segment morphology and intraocular pressure in normal cats and cats with primary congenital glaucoma.

Authors:  Filipe Espinheira Gomes; Ellison Bentley; Ting-Li Lin; Gillian J McLellan
Journal:  Vet Ophthalmol       Date:  2011-09       Impact factor: 1.644

3.  Muscarinic receptor antagonist and an alpha-adrenergic agonist are required in combination to provide stable mydriasis following intravitreal injection in mice.

Authors:  Deb Kumar Mojumder
Journal:  Biol Med (Aligarh)       Date:  2010-01-01

4.  Effects of topical atropine on intraocular pressure and myopia progression: a prospective comparative study.

Authors:  Chia-Yi Lee; Chi-Chin Sun; Yi-Fang Lin; Ken-Kuo Lin
Journal:  BMC Ophthalmol       Date:  2016-07-19       Impact factor: 2.209

5.  Changes in intraocular pressure and horizontal pupil diameter during use of topical mydriatics in the canine eye.

Authors:  Liga Kovalcuka; Agris Ilgazs; Dace Bandere; David L Williams
Journal:  Open Vet J       Date:  2017-01-27

6.  Changes in intraocular pressure, horizontal pupil diameter, and tear production during the use of topical 1% cyclopentolate in cats and rabbits.

Authors:  Liga Kovalcuka; Madara Nikolajenko
Journal:  Open Vet J       Date:  2020-03-14

7.  A STROBE-compliant case-control study: Effects of cumulative doses of topical atropine on intraocular pressure and myopia progression.

Authors:  Teng-Chieh Yu; Tzu-En Wu; Yuan-Shen Wang; Shen-Fu Cheng; Shiow-Wen Liou
Journal:  Medicine (Baltimore)       Date:  2020-11-25       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.